Literature DB >> 26344401

Predictors and outcomes for chronic tracheostomy after chemoradiation for advanced laryngohypopharyngeal cancer.

Gina D Jefferson1, Barry L Wenig1, Michael T Spiotto2,3.   

Abstract

OBJECTIVES/HYPOTHESIS: After concurrent chemoradiation for head and neck squamous cell cancer, patients with laryngeal incompetence may not recover function. We assessed variables predicting tracheostomy dependence as a measure of poor laryngeal function after chemoradiation. STUDY
DESIGN: Retrospective
METHODS: Analysis of 109 patients treated with chemoradiation for locoregionally advanced laryngohypopharyngeal squamous cell cancers between 1992 and 2013. Median follow-up was 17.0 and 17.2 months for tracheostomy and nontracheostomy dependent patients, respectively.
RESULTS: For all patients, multivariate analysis demonstrated persistent tracheostomy was associated with pretreatment tracheostomy, subglottic extension, three-dimensional conformal radiotherapy (3DCRT) and postradiotherapy lymphadenectomy. When analyzed by primary site, tracheostomy dependence was associated with pretreatment tracheostomy, subglottic extension, and 3DCRT in larynx primaries, and with pretreatment tracheostomy and feeding tube dependency in hypopharynx primaries. Tracheostomy dependence did not impact local control, progression-free survival or overall survival on univariate analysis.
CONCLUSION: After curative chemoradiation, long-term tracheostomy was associated with pretreatment tracheostomy, subglottic extension, postradiotherapy lymphadenectomy, and 3DCRT but did not impact outcomes. These factors may inform treatment decision making regarding organ preservation approaches for locally advanced laryngeal and hypopharyngeal cancers. LEVEL OF EVIDENCE: 4.
© 2015 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Squamous cell carcinoma; concurrent chemoradiotherapy; larynx cancer; organ preservation; tracheostomy

Mesh:

Year:  2015        PMID: 26344401     DOI: 10.1002/lary.25585

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth?

Authors:  Abrahim Al-Mamgani; Arash Navran; Iris Walraven; Willen Hans Schreuder; Margot E T Tesselaar; Willem Martin C Klop
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-12-18       Impact factor: 2.503

2.  Long-term functional outcome after laryngeal cancer treatment.

Authors:  Lukas Anschuetz; Mohamed Shelan; Marco Dematté; Adrian D Schubert; Roland Giger; Olgun Elicin
Journal:  Radiat Oncol       Date:  2019-06-11       Impact factor: 3.481

Review 3.  Systematic review and meta-analysis of transoral laser microsurgery in hypopharyngeal carcinoma.

Authors:  Ciaran Lane; Rasheda Rabbani; Janice Linton; S Mark Taylor; Norbert Viallet
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-01-14

4.  Posttreatment Non-Improved Vocal Cord Mobility Indicates the Need of Salvage Surgery for Hypopharyngeal Carcinomas.

Authors:  Yu-Qin He; Xi-Wei Zhang; Yi-Ming Zhu; Xiao-Guang Ni; Ze-Hao Huang; Chang-Ming An; Jun-Lin Yi; Shao-Yan Liu
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

5.  [Larynx preservation: recommendations for decision-making in T3 laryngeal cancer patients].

Authors:  Gerhard Dyckhoff; Rolf Warta; Christel Herold-Mende; Peter K Plinkert; Heribert Ramroth
Journal:  HNO       Date:  2022-05-16       Impact factor: 1.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.